Ball Corporation didn’t invent the aluminum can, but it mastered the business of making them. At the start of the 2010s, beverage packaging was a commoditized, cyclical industry defined by razor‑thin margins and intense price competition. Investors largely ignored Ball, a 140‑year‑old company largely known for jars and cans, until its leadership quietly consolidated the market and went from just another vendor to the supplier.
📊 Snackable Stat: 39% market share
Ball’s beverage packaging EMEA segment notes that the aluminum beverage container market in the countries where it operates is roughly 93 billion cans a year. Ball is the largest producer in the region, supplying about 39% of shipments, giving it near-unrivaled bargaining power with suppliers and customers, explaining why the company can earn mid‑teens margins in a business many assume is a commodity.
Here’s what you’ll learn:
How consolidation created a quasi‑monopoly in aluminum cans and why scale matters in commodity packaging.
How diversification brought balance to cyclical packaging profits.
How boring businesses can deliver stellar returns, and commodity markets may look unsexy but are cash machines.

Trapped in the Commodity Game
Here’s the problem with making aluminum cans, they’re all basically the same. Coca-Cola could switch can suppliers tomorrow, and consumers wouldn't notice. Prices moved up and down with aluminum costs. Historically, this is an industry where there’s no loyalty, little switching costs, and virtually nothing to stop customers from walking away. The entire industry has survived on paper-thin profits and constant price wars.
Ball Corp’s leadership saw one way out of this cycle: get massive. If you're big enough, you stop being just another supplier. You become someone aluminum producers have to negotiate with, a player who can lock in long-term deals. Someone who runs so many plants that closing a few bad ones barely matters. The supplier that customers can't easily replace.
But to get that big, and command that type of power, required a gamble that would either transform Ball or bury them in debt.

Get Big or Get Out
Ball's escape plan had two parts that, to most, would never seem connected.
In 2016, they made their move, acquiring Rexam, Europe’s biggest beverage can manufacturer. Overnight, they became a heavyweight, to the point where regulators forced them to sell off some facilities to competitors, but they were already a heavyweight. pumping out about 100 billion cans a year. The plan was simple: cut $300 million in costs within three years. Nearly half would come from firing redundant executives and closing duplicate offices. Another third from buying materials in bulk and negotiating harder. The rest from smarter shipping and optimizing logistics. Then they'd close expensive plants, standardize how everything worked, and start passing costs to customers instead of eating them.
The Aerospace Hedge
Ball entered aerospace decades prior, having been building spacecrafts since 1956. What started as a partnership with University of Colorado physicists grew into a premier aerospace contractor, producing nearly $2B in revenues by 2023 from building satellites, instruments, and defense tech. This business did something that the beverage business couldn't: deliver predictable, high-margin revenue. NASA contracts lasted years, work with the DoD came with built in escalations. By the end of 2023, the Ball Aerospace division had $2.98 Billion in backlog, plus another $5.9 Billion in contracts that hadn't been formally booked yet, many of which were cost-plus agreements where the government guaranteed margins.
These weren’t just any projects, the division supplied critical instruments for NASA’s most ambitious missions. Ball built all 18 beryllium mirror segments for the James Webb Space Telescope, working as the main subcontractor to Northrop Grumman. The lightweight mirrors essentially allow astronomers to see back in time and detect faint infrared light from the early universe. They also developed TEMPO, an air quality instrument that sits in geostationary orbit scanning North America every hour, tracking ozone, nitrogen dioxide, sulfur dioxide, and formaldehyde. Its real-time data will help scientists and public health officials trace pollution sources and movement.
When sales dropped during recessions, aerospace contracts kept cash flowing. When aerospace programs got delayed (as they often do), packaging threw off steady cash.

Knowing When to Cash Out
By 2023, scale had delivered everything Ball wanted. They controlled 38% of Europe's 90 billion-can market and 47% of South America's 41 billion cans. With only a handful of real competitors left, Ball could focus on higher-margin specialty cans instead of commodity products. The numbers proved it as North American operating profit grew 11% even as revenue fell by the same amount. That’s the type of luxury having pricing control gives you. With the aerospace division also thriving, leadership knew it was time to strike. In August 2023 they Ball sold the entire division to BAE Systems for $5.6B, at roughly 20x EBITDA. They immediately put the cash to work, paying down debt, share buybacks and strengthening the balance sheet. These moves returned nearly $2B to shareholders in 2024 alone.
Most CEOs would have held on, but the logic behind the sale was sound. Aerospace required constant R&D and had started competing for talent with companies like SpaceX and Lockheed. By now, packaging was a cash machine, dominating three continents, and didn’t need aerospace’s stability anymore. With aerospace gone, they refocused bets on the core packaging business. Today, they’re a pure play packaging giant that you’ve probably never heard of.
Here are the takeaways you can apply…
Scale Turns Commodities Into Profits. Even in low-margin industries, getting big enough changes the rules. Consolidation can bring pricing power, cost efficiencies, and bargaining leverage with both suppliers and customers.
Efficiency Creates Hidden Growth. Shutting down high-cost plants, standardizing operations, and passing inflation through contracts turned a stagnant industry into a cash generator. Small operational optimizations compound into outsized gains.
Diversification Works Until It Doesn’t. Ball’s aerospace unit balanced out packaging’s ups and downs for decades. But when complexity and capital demands increased, outweighing the benefits, management exited at peak value. Know when to cash out.

In Partnership With
100+ ChatGPT Prompts to Revolutionize Your Day
Supercharge your productivity with HubSpot's comprehensive guide. This free resource is your fast track to AI mastery:
Industry-Specific Use Cases: 15+ real-world applications across various sectors
Productivity Guide: 21 best practices to 10x your efficiency with AI
Prompt Powerhouse: 100+ ready-to-use prompts for immediate implementation
Challenge Buster: Overcome common AI hurdles with expert strategies
Plus, in-depth sections on email composition, content creation, customer support, and data analysis.

🍫 Power Numbers
39% – Ball’s share of a 93 billion‑can EMEA market; its 19 plants shipped 36 billion cans in 2024.
47% – Ball’s estimated share of South America’s 43 billion‑can market.
$4.5B – How much Ball made post-tax after selling their aerospace division to BAE Systems.
$1.96B – How much Ball Corp returned to shareholders in 2024.

🍭 More Sweet Reads
Launching a company can be thrilling, until you hit the Wilderness Period, that tough stretch between shipping your MVP and landing your first real, unaffiliated paying customers. It’s the true test of your product’s value, where founders must adapt quickly and turn feedback into sales. Only by “crossing the Penny Gap” do you prove real demand and move toward sustainable growth.
The tools you use. The data you trust. The GTM strategies you build. Ever wonder who's shaping them? We're in the middle of a GTM Renaissance, a new era where creativity, data, and bold experimentation are colliding to build something better. It's time to ditch stale cadences, break away from predictable funnels, and start building a GTM engine powered by intelligence, imagination, and speed. Get the tools.
Microsoft researchers recently discovered that open-source AI protein design tools could be exploited to generate thousands of synthetic toxin variants, many of which are able to evade existing DNA synthesis biosecurity checks. Their work, published in Science, unveiled a critical global vulnerability, prompting a collaborative response across the industry to urgently upgrade and fortify biosecurity screening systems for dangerous biological materials.
Need to improve your tech stack? Would a free year from Atlassian, Amplitude, Intercom, Serverspace, and GitHub help? How about $50K credits from Segment and Mixpanel or cashback on tools like Apollo, Instantly, and Dripify? Here’s a cost-effective resource to help you upgrade without breaking the bank.

Want to reach 50,000+ technologists, decision makers, and business-savvy readers? Partner with us.